ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry's leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
ARMI COO Jennifer MacDonald, MD, will moderate a closing session on preparing New Hampshire health care providers for regenerative medicine at the 2026 NHHA/FHC Annual Meeting.
ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
Meeting in the Millyard 2027 (MITM27) marks the 10-year anniversary of ARMI | BioFabUSA’s flagship convening bringing together leaders across biomanufacturing, regenerative medicine, healthcare, manufacturing, workforce development, government, and industry to help shape the next decade of bioindustrial capability.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
